Proposed Collection; Comment Request for Information Collection Tool Relating to the Orphan Drug Credit, 51451 [2021-19880]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 176 / Wednesday, September 15, 2021 / Notices
comments will become a matter of
public record. Comments are invited on:
(a) Whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information.
Approved: September 2, 2021.
ChaKinna B. Clemons,
Supervisory Tax Analyst.
[FR Doc. 2021–19879 Filed 9–14–21; 8:45 am]
BILLING CODE 4830–01–P
DEPARTMENT OF THE TREASURY
Internal Revenue Service
Proposed Collection; Comment
Request for Information Collection
Tool Relating to the Orphan Drug
Credit
Internal Revenue Service (IRS),
Treasury.
ACTION: Notice and request for
comments.
AGENCY:
The Internal Revenue Service,
as part of its continuing effort to reduce
paperwork and respondent burden,
invites the general public and other
Federal agencies to take this
opportunity to comment on continuing
information collections, as required by
the Paperwork Reduction Act of 1995.
The IRS is soliciting comments
concerning the orphan drug credit.
DATES: Written comments should be
received on or before November 15,
2021 to be assured of consideration.
ADDRESSES: Direct all written comments
to Kinna Brewington, Internal Revenue
Service, Room 6526, 1111 Constitution
Avenue NW, Washington, DC 20224.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the form should be directed to
Kerry Dennis, at (202) 317–5751 or
Internal Revenue Service, Room 6526,
1111 Constitution Avenue NW,
Washington, DC 20224, or through the
internet, at Kerry.Dennis@irs.gov.
SUPPLEMENTARY INFORMATION:
Title: Orphan Drug Credit.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:08 Sep 14, 2021
Jkt 253001
OMB Number: 1545–1505.
Form Number: 8820.
Abstract: Filers use this form to elect
to claim the orphan drug credit, which
is 50% of the qualified clinical testing
expenses paid or incurred with respect
to low or unprofitable drugs for rare
diseases and conditions, as designated
under section 526 of the Federal Food,
Drug, and Cosmetic Act.
Current Actions: There is no change
in the form or paperwork burden
previously approved by OMB.
Type of Review: Extension of a
currently approved collection.
Affected Public: Business or other forprofit organizations.
Estimated Number of Respondents:
67.
Estimated Time per Response: 4
hours, 42 min.
Estimated Total Annual Burden
Hours: 316.
The following paragraph applies to all
the collections of information covered
by this notice.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless the collection of information
displays a valid OMB control number.
Books or records relating to a collection
of information must be retained if their
contents may become material in the
administration of any internal revenue
law. Generally, tax returns and tax
return information are confidential, as
required by 26 U.S.C. 6103.
Request for Comments: Comments
submitted in response to this notice will
be summarized and/or included in the
request for OMB approval. All
comments will become a matter of
public record. Comments are invited on:
(a) Whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information.
Approved: September 2, 2021.
ChaKinna B. Clemons,
Supervisory Tax Analyst.
[FR Doc. 2021–19880 Filed 9–14–21; 8:45 am]
BILLING CODE 4830–01–P
PO 00000
Frm 00114
Fmt 4703
Sfmt 4703
51451
DEPARTMENT OF VETERANS
AFFAIRS
[OMB Control No. 2900–0587]
Agency Information Collection
Activity: VAAR Clause 852.211–70,
Equipment Operation and Maintenance
Manuals
Office of Acquisition and
Logistics, Department of Veterans
Affairs.
ACTION: Notice.
AGENCY:
Office of Acquisition and
Logistics (OAL), Department of Veterans
Affairs (VA), is announcing an
opportunity for public comment on the
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act (PRA) of
1995, Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of a currently approved
collection, and allow 60 days for public
comment in response to the notice.
DATES: Written comments and
recommendations on the proposed
collection of information should be
received on or before November 15,
2021.
ADDRESSES: Submit written comments
on the collection of information through
Federal Docket Management System
(FDMS) at www.Regulations.gov or to
Bogdan Vaga, Office of Acquisition &
Logistics, Procurement Policy & Warrant
Management Services (003A2A),
Department of Veterans Affairs, 810
Vermont Avenue NW, Washington, DC
20420 or email to Bogdan.Vaga@va.gov.
Please refer to ‘‘OMB Control No. 2900–
0587’’ in any correspondence. During
the comment period, comments may be
viewed online through FDMS.
FOR FURTHER INFORMATION CONTACT:
Maribel Aponte, Office of Enterprise
and Integration, Data Governance
Analytics (008), 1717 H Street NW,
Washington, DC 20006, (202) 266–4688
or email maribel.aponte@va.gov. Please
refer to ‘‘OMB Control No. 2900–0587’’
in any correspondence.
SUPPLEMENTARY INFORMATION: Under the
PRA of 1995, Federal agencies must
obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. This request for comment is
being made pursuant to Section
3506(c)(2)(A) of the PRA. With respect
to the following collection of
information, OAL invites comments on:
(1) Whether the proposed collection of
information is necessary for the proper
performance of OAL’s functions,
SUMMARY:
E:\FR\FM\15SEN1.SGM
15SEN1
]]>Agencies
[Federal Register Volume 86, Number 176 (Wednesday, September 15, 2021)]
[Notices]
[Page 51451]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19880]
-----------------------------------------------------------------------
DEPARTMENT OF THE TREASURY
Internal Revenue Service
Proposed Collection; Comment Request for Information Collection
Tool Relating to the Orphan Drug Credit
AGENCY: Internal Revenue Service (IRS), Treasury.
ACTION: Notice and request for comments.
-----------------------------------------------------------------------
SUMMARY: The Internal Revenue Service, as part of its continuing effort
to reduce paperwork and respondent burden, invites the general public
and other Federal agencies to take this opportunity to comment on
continuing information collections, as required by the Paperwork
Reduction Act of 1995. The IRS is soliciting comments concerning the
orphan drug credit.
DATES: Written comments should be received on or before November 15,
2021 to be assured of consideration.
ADDRESSES: Direct all written comments to Kinna Brewington, Internal
Revenue Service, Room 6526, 1111 Constitution Avenue NW, Washington, DC
20224.
FOR FURTHER INFORMATION CONTACT: Requests for additional information or
copies of the form should be directed to Kerry Dennis, at (202) 317-
5751 or Internal Revenue Service, Room 6526, 1111 Constitution Avenue
NW, Washington, DC 20224, or through the internet, at
[email protected].
SUPPLEMENTARY INFORMATION:
Title: Orphan Drug Credit.
OMB Number: 1545-1505.
Form Number: 8820.
Abstract: Filers use this form to elect to claim the orphan drug
credit, which is 50% of the qualified clinical testing expenses paid or
incurred with respect to low or unprofitable drugs for rare diseases
and conditions, as designated under section 526 of the Federal Food,
Drug, and Cosmetic Act.
Current Actions: There is no change in the form or paperwork burden
previously approved by OMB.
Type of Review: Extension of a currently approved collection.
Affected Public: Business or other for-profit organizations.
Estimated Number of Respondents: 67.
Estimated Time per Response: 4 hours, 42 min.
Estimated Total Annual Burden Hours: 316.
The following paragraph applies to all the collections of
information covered by this notice.
An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless the collection of
information displays a valid OMB control number. Books or records
relating to a collection of information must be retained if their
contents may become material in the administration of any internal
revenue law. Generally, tax returns and tax return information are
confidential, as required by 26 U.S.C. 6103.
Request for Comments: Comments submitted in response to this notice
will be summarized and/or included in the request for OMB approval. All
comments will become a matter of public record. Comments are invited
on: (a) Whether the collection of information is necessary for the
proper performance of the functions of the agency, including whether
the information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the collection of information; (c)
ways to enhance the quality, utility, and clarity of the information to
be collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information.
Approved: September 2, 2021.
ChaKinna B. Clemons,
Supervisory Tax Analyst.
[FR Doc. 2021-19880 Filed 9-14-21; 8:45 am]
BILLING CODE 4830-01-P
